Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

4 CLINICS GROUP

UEI: L3DEF9AMKPV8

4 CLINICS GROUP is a federal contractor, registered under UEI L3DEF9AMKPV8. It has been awarded $155,000 in federal contracts. Primary work spans In-Vitro Diagnostic Substance Manufacturing. Top awarding agencies include Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

L3DEF9AMKPV8

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

4 Clinics Group provides specialized clinical research and scientific support services. Their core capabilities include medical writing, biostatistics, epidemiology, and medical monitoring. The firm possesses technical expertise in managing complex clinical trial phases and providing ad hoc consulta...

Key Performance Metrics

Awards Count

3

All time

Active

0

Currently performing

Completed

3

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services (hhs)$155.0K100%

Awards by NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing$155.0K100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with 4 CLINICS GROUP

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for 4 CLINICS GROUP

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in 4 CLINICS GROUP's top NAICS codes and agencies

CONTROL SET, GLUCOSE

Solicitation # SPE2DS-27-T-1307

Solicitation SPE2DS-27-T-1307 is a request for quotations issued by DLA Troop Support, Medical Supply Chain MD SURG FSF for the procurement of one glucose control set (NSN 6550-01-642-5011) compatible with the Accu-Chek Inform II system. Each set must contain 2.5 mL of Level 1 and Level 2 solutions and be stored between 39-86 degrees Fahrenheit. The items are subject to a non-extendable 24-month shelf life, with a requirement that no more than three months elapse between the date of manufacture and the date of delivery to the government. Delivery is required within 20 days after receipt of the order, with the point of inspection and acceptance set as destination. The contractor must adhere to strict medical packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and utilize sealed unit containers, with palletization following RP001 requirements. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system. The solicitation incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and the HUBZone price evaluation preference. Offerors must maintain updated representations and certifications in the System for Award Management and submit quotes via the DIBBS portal.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 12 hours ago

DEADLINE

6550--Optilite analyzer reagents

Solicitation # 36C26227Q0052

The Department of Veterans Affairs Network Contracting Office 22 is soliciting quotes for a Firm-Fixed Price Blanket Purchase Agreement to provide FDA approved reagents, consumables, and supplies specifically validated for use on the Optilite analyzer. The procurement includes essential items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagent kits, along with various washing solutions, maintenance solutions, sample diluents, and TENCELL cuvettes. All materials must be manufactured by Binding Site Laboratories to ensure system performance and safety. Additionally, Amendment 0001 expanded the scope to include a service contract for an Optilite equipment model, requiring on-site preventive maintenance and corrective repair services at the Southern Arizona VA Health Care System in Tucson, Arizona. The estimated period of performance spans sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. Deliveries are required within four working days of order placement to various VA Medical Centers across California, Arizona, and New Mexico, with the vendor bearing all shipping costs. Award will be granted to the responsible offeror who is determined technically acceptable and offers the lowest price. Quotes must be submitted via email to Carlos Magana by November 5, 2026, at 9:00 AM PST, and must include a detailed capability response addressing the Statement of Work and comprehensive pricing for the base and option years.

262-NETWORK Contract Office 22 (36C262)

POSTED

about 17 hours ago

DEADLINE

Flow Cytometry Reagents

Solicitation # 36C24527Q0053

This Request for Information (RFI) is issued by the Department of Veterans Affairs for the purpose of planning and information gathering. It seeks potential sources to provide reagents and supplies for flow cytometry testing at the Baltimore VAMC within the Hematology section of the Pathology and Laboratory Medicine Service. The required materials will be used for CD4/CD8 count testing and the phenotyping of white blood cells in leukemia and lymphoma assays, specifically for use with the Becton Dickinson FACSLyric system. The scope includes a detailed list of specific reagents, buffers, and quality control calibration materials, such as BD FC Beads, to monitor daily performance and spectral overlap. The anticipated performance period is from December 3, 2026, to December 2, 2027. Because this is a sources-sought notice and not a formal solicitation, the final acquisition strategy, contract type, and evaluation methodology are still to be determined. Interested respondents must provide company identification, including their CAGE code and SAM UEI, and specify whether they are a manufacturer or distributor. Additionally, they must provide the country of origin for all products, technical literature demonstrating that their products meet or exceed the specified brand name requirements, and a current authorized distributor letter certified by the OEM.

245-NETWORK Contract Office 5 (36C245)

POSTED

about 17 hours ago

DEADLINE

65--NOI - DNA Sequencing of Bone Marrow Failure Syndro

Solicitation # 75N98027Q00027

The National Institutes of Health, Office of the Director, Office of Acquisitions, is seeking a firm-fixed-price contract for custom-designed ArcherDX VariantPlex Next-Generation Sequencing target-enrichment library preparation kits. These kits will be utilized by the NHLBI Hematology Branch to screen over 200 patient samples for bone marrow failure syndromes and aplastic anemia, specifically targeting low-frequency somatic mutations. To maintain scientific continuity and compatibility with the laboratory's established Archer Analysis bioinformatics pipeline and Illumina NovaSeq instruments, the kits must utilize proprietary ArcherDX VariantPlex Anchored Multiplex PCR chemistry and incorporate unique molecular barcodes for error-correcting sequencing. Solicitation 75N98027Q00027 was initially issued as a non-competitive notice of intent to award to Integrated DNA Technologies, Inc. However, Amendment 0001 transitioned the procurement strategy to a brand-name competitive simplified acquisition using the Lowest-Price Technically Acceptable source selection process. The requirement falls under NAICS code 325413 and is not set aside for small businesses. The estimated delivery turnaround time is four to six weeks after receipt of order, with a final response deadline of November 5, 2026.

National Institutes Of Health Olao

POSTED

about 17 hours ago

DEADLINE

ITN-491-270000000004-1 | Sure Check Chembio HIV Test Kits

Solicitation # ITN-491-270000000004

The Michigan Department of Health and Human Services, Division of HIV and STD Programs, has issued solicitation ITN-491-270000000004 for a multi-year contract to procure SURE CHECK HIV 1/2 Assays and related components from Chembio Diagnostics Systems, Inc. This procurement is structured as a sole-source intent because Chembio is the only manufacturer of the specific assay required to implement a dual rapid algorithm for point-of-care HIV blood testing. The required test kits must provide results within 20 minutes and maintain a shelf life of two years. These materials are critical for conducting confirmatory HIV blood tests at non-clinical sites and will be distributed to covered entities to serve at-risk populations. The agency has determined that purchasing directly from the manufacturer is an operational necessity to ensure accurate testing and counseling and provides significant cost efficiency over third-party distributors. The solicitation was posted on November 2, 2026, with a response deadline of November 9, 2026, for any parties wishing to challenge the sole-source intent by offering an equivalent product via the SIGMA portal. Vicki Moore serves as the Solicitation Manager for this effort, which will be performed within the state of Michigan.

POSTED

DEADLINE

Hepatitis B Surface Antigen Determination Test Kit SupplierThis subcontract involves the supply of specialized medical diagnostic test kits for the in-vitro detection of Hepatitis B surface antigen in human serum and plasma. The kits must meet NSN 6550-01-664-2387 and adhere to all applicable in-vitro diagnostic standards and DLA quality requirements. The total delivery requirement consists of 1,000 packages, with each package containing 100 test kits. The contract is managed by the Department of Defense under the Medical Supply Chain MD Surg FSF agency, falling under NAICS code 325413. Performance will take place at FPO 09566-4008. The solicitation was posted on November 1, 2026, with a response deadline of November 9, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Gram Negative Panel Culture Controls SupplierThis subcontract involves the supply of Gram Negative Panel Culture Controls for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The scope of work requires the manufacture or provision of quality control organisms under NSN 6550-01-713-4926, specifically in a disposable Inculti-Loops format stabilized within a gel matrix. The supplier must ensure strict adherence to Medical Marking Standard No. 1 and 29 CFR 1910.1200, while maintaining a rigorous cold chain transport temperature between 2 to 8 degrees Celsius. Performance for this contract is based in Williamsburg, Virginia, under NAICS code 325413, with the final deliverable being the completed product packages.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, THYROXINE DET

Solicitation # SPE2DS-27-T-1221

Solicitation SPE2DS-27-T-1221 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of thyroxine determination test kits (NSN 6550-01-664-2364). The required product is the Vitros Immunodiagnostic Free T4 Reagent Pack, which consists of 100 coated wells and 13.3 ml of conjugate reagent. These kits are subject to strict environmental controls, requiring refrigeration between 2-8 degrees Celsius and must not be frozen. The items have a non-extendable shelf life of six months, and no more than three weeks may elapse between the date of manufacture and the date of delivery to the government. Delivery is required within 20 days of order, with the destination and acceptance point located at the USNS Comfort (FPO AE 09566-4008). Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, while marking must adhere to Medical Marking Standard No. 1. Because the materials may be hazardous, the contractor must provide Safety Data Sheets (SDS) and labels in accordance with 29 CFR 1910.1200. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with various DFARS clauses regarding cybersecurity, the Buy American Act, and the safeguarding of covered defense information.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-27-T-1193

Solicitation SPE2DS-27-T-1193 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of two boxes of i-STAT PT Plus Control Reagent Level 1. This blood chemistry control is used for coagulation testing on the i-STAT 1 Government Field Kit analyzer. Each box contains ten 1.0 mL units. The items are regulated by the FDA under Regulation 864.7750 Class II and must be delivered FOB Destination to the USNS Comfort within 20 days after the order. The contract mandates strict quality and storage requirements, including refrigeration between 2 to 8 degrees Celsius and a non-extendable shelf life of 12 months. To ensure product viability, no more than one month may have elapsed from the date of manufacture to the date of delivery. Packaging must adhere to MIL-STD-2073-1E and Medical Marking Standard No. 1, with labels specifying the manufacture date, expiration date, and contract or lot number. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-1178

Solicitation SPE2DS-27-T-1178 is a small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter home use. The requirement is for 6 cases, with each case containing 12 kits and each kit containing 2 tests. The items must be stored between 2 and 30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of the order, with the destination and inspection point designated as the USNS Henson T AGS 63 in FPO AE 09573. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires all labels to include the contract or lot number and the manufacture, expiration, or retest date. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers in accordance with MIL-STD-2073-1E and DLA packaging requirement RP001. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment. The procurement is subject to various federal regulations, including the Buy American Act, DFARS cybersecurity reporting standards, and the HUBZone price evaluation preference.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CULTURE CONTROL, GRAM N

Solicitation # SPE2DS-27-T-1182

Solicitation SPE2DS-27-T-1182 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Gram Negative Panel Culture Controls (NSN 6550-01-713-4926). The product consists of a ready-to-use set of six quality control organisms in a disposable Inculti-Loops format, stabilized in a gel matrix and requiring storage between 2 to 8 degrees Celsius. The items are subject to a non-extendable shelf life of nine months, with a requirement that no more than one month has elapsed from the date of manufacture to the date of delivery. Delivery is required within five days after receipt of order to the Naval Medical Readiness Logistics Command in Williamsburg, Virginia, with both inspection and acceptance occurring at the destination. The contractor must adhere to commercial packaging and packing standards, utilizing sealed unit containers and commercial exterior shipping containers. Marking and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and include the contract/lot number and relevant manufacture or expiration dates. Invoicing and payment shall be processed electronically through the Wide Area WorkFlow system. This acquisition is subject to various federal regulations, including the Buy American Act, DFARS cybersecurity reporting requirements, and specific hazardous material labeling standards under 29 CFR 1910.1200. The award may be subject to the HUBZone price evaluation preference and is potentially eligible for automated award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

6550--Copy of 629-27-1-042-0024 Roche Ventana Reagents 36C256-27-AP-0548 36C25625D0002 (Current IDIQ- ends 10/15/2026) PND CHANGED TO 11/16/2026

Solicitation # 36C25627Q0074

The Department of Veterans Affairs, Veterans Integrated Service Network 16, is soliciting an unrestricted, five-year firm-fixed-price Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply Immunohistochemistry and Special Stain reagents for Roche Ventana staining platforms. The contract will support the Anatomic Pathology Section of the Southeast Louisiana Veterans Health Care System in New Orleans, Louisiana. The period of performance runs from November 16, 2026, through November 15, 2031, with a guaranteed minimum value of $10,000. Individual task orders will range from a minimum of $2,000 to a maximum of $400,000. Award will be determined using the Lowest Priced Technically Acceptable (LPTA) process, evaluating offerors on a pass/fail basis regarding their technical capabilities, personnel, and quality control procedures. The selected contractor must ensure all reagents are delivered in original manufacturer packaging, maintained at appropriate temperatures, and arrive within five business days of order placement. Reagents must have expiration dates of at least nine months from delivery when commercially available. The procurement falls under NAICS code 325413 for In Vitro Substance Manufacturing. Interested offerors must submit their technical and price proposals, including the Roche Ventana Reagents Item Price List and a completed SF-1449, by November 9, 2026. Invoicing must be processed electronically through the VA-approved Tungsten system.

256-NETWORK Contract Office 16 (36C256)

POSTED

DEADLINE

5 Year Service Agreement Panther Fusion Plus

Solicitation # KR27-109

The State of Utah has issued a notice of intent to award a five year service agreement for Panther Fusion Plus under solicitation number KR27-109. This procurement is being pursued without a standard competitive bidding process, as the Conducting Procurement Unit has requested a sole source award based on the determination that only one provider can supply the required items or services. The notice was posted on October 30, 2026, with a response deadline of November 6, 2026. Interested parties or reviewers are directed to the provided documentation to examine the specific justifications for bypassing the standard procurement process. The primary point of contact for this action is Kaitlyn Riley.

POSTED

DEADLINE

Blood Type IVD Reagents and Sera SupplyThis subcontract involves the supply of Blood Type IVD Reagents and Sera to prime contractors supporting Department of Veterans Affairs VISN 22 medical supply contracts. The scope of work includes the manufacture or distribution of ABO reverse typing cells, antibody screening cells, and antibody identification cells, as well as the provision of Lewis Blood Group Substance and full antigen profiles. All delivered reagents must be FDA compliant and accompanied by Certificates of Analysis or Conformance. The contract is managed by the Network Contract Office 22 under NAICS code 325413, with a response deadline set for November 16, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6550--Blood Type IVD Reagents

Solicitation # 36C26227Q0043

The Department of Veterans Affairs, through the Network Contract Office 22, is seeking quotations for solicitation 36C26227Q0043 to establish a Blanket Purchase Agreement for blood type IVD reagents, supplies, and consumables for manual testing at VISN 22 facilities. The contract is structured with a 12-month base ordering period and four subsequent 12-month option periods, for a total potential duration of five years. This is a commercial products and services acquisition under FAR Part 12, with an emphasis on FDA regulatory compliance, potency requirements, and strict cold-chain and temperature-monitoring controls during shipment. All items must be quoted as F.O.B. destination and delivered Monday through Friday between 8am and 4pm. Award will be based on the best value to the government, evaluated through a comparative assessment of technical understanding, price, and quality, regulatory compliance, and product traceability. Technical evaluation considers the offeror's ability to provide a full antigen profile and their procedures for handling nonconforming or defective products. Pricing will be evaluated based on the total cost for the base period and all option periods, including a six-month price addition for the final performance period per FAR 52.217-8. Quotations must be submitted via email to the contract specialist by November 16, 2026, and must include a completed five-year pricing spreadsheet, a past performance questionnaire, and required certifications regarding telecommunications and trade agreements.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6550--Abbott Architect i1000 Reagents and Consumables

Solicitation # 36C26227Q0073

Solicitation 36C26227Q0073 is a firm-fixed-price contract opportunity issued by the Department of Veterans Affairs, Network Contracting Office 22, for the procurement of Abbott Architect i1000 reagents and consumables. The scope includes the supply of FDA-approved reagents, controls, calibration materials, disposables, and consumable parts that must be fully compatible with the existing Architect i1000 analyzer without alteration. This acquisition is 100 percent set aside for small businesses under NAICS code 325413. The period of performance is scheduled from December 12, 2026, to December 11, 2027, with items to be ordered as needed. Performance will take place in Tucson, Arizona. The government will award the contract to the responsible offeror whose proposal is most advantageous, based on a combination of price and technical acceptability. Technical evaluation focuses on whether the offered products meet all salient characteristics, and any items deemed unacceptable will result in the entire offer being rejected. Offerors must provide clear evidence for any equal-to items and a Letter of Authorization from the Original Equipment Manufacturer to ensure products are not gray market or counterfeit. The submission deadline is November 13, 2026, at 1:00 PM Pacific Time. The contract also includes provisions for an option to increase quantity and a potential service extension of up to six months.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Reagents and consumables for Roche immunostainers

Solicitation # 75N98027Q00026

Solicitation 75N98027Q00026 is a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract issued by the National Institutes of Health Office of Logistics and Operations. The objective is to procure proprietary reagents, kits, and consumables compatible with the National Cancer Institute's Roche Ventana Benchmark ULTRA and Benchmark Plus immunostainers. The contract includes a base year starting December 1, 2026, with four subsequent option years, carrying a minimum value of 20,000 dollars and a maximum value of 1.5 million dollars. The scope of work extends beyond supplies to include no-cost software upgrades, VConnect software coverage, and professional consultation from scientists and engineers. The contractor must adhere to strict quality and delivery standards, including overnight shipping using industry-best practices such as dry or wet ice, and ensuring all reagents have expiration dates exceeding 12 months from the shipping date. Deliveries are f.o.b. destination to Bethesda, Maryland, and must typically be completed within five days of a task order. Award will be based on a best value tradeoff evaluation considering technical proposal, equipment capability, delivery, and price. Offerors must provide a Unique Entity Identifier, Taxpayer Identification Number, and business size certification, with responses due by November 16, 2026.

National Institutes Of Health Olao

POSTED

DEADLINE

REAGENT POWDER — 6640015207401 — N0010426QEJ19

Solicitation # N0010426QEJ19

Solicitation N00104-26-Q-EJ19 is a fixed-price request for quotation issued by NAVSUP Weapons Systems Support for the procurement of Reagent Powder (NSN 6640-01-520-7401), manufactured by Idexx Distribution Corp. The requirement consists of 60 packages, with each package containing 200 units. Delivery is scheduled incrementally in four shipments of 15 packages each, starting on or around April 15, 2027, with subsequent deliveries every 90 days. The items are shelf-life sensitive with a 12-month duration, and they must be supplied with at least 85 percent of their shelf life remaining at the time of shipment. The contract mandates strict adherence to MIL-STD-129 for marking and labeling, and packaging must comply with MIL-STD-2073-1 or ASTM D3951-18 depending on the destination. Key deliverables include a Certificate of Compliance per DI-MISC-81356 and a cure date certificate per DI-MISC-81318, both submitted at the time of material delivery. Award will be made to the responsible offeror providing the lowest priced, technically acceptable offer. Inspection and acceptance are designated at the origin, and the contractor is required to maintain a government-acceptable inspection system. Additionally, the contract prohibits the intentional addition of mercury and requires compliance with hazardous material identification and safety data sheet regulations.

Navsup Weapon Systems Support Mech

POSTED

DEADLINE